ZM 449829 free base · Synonyms: ZM-449829 · ZM449829
ZM 449829 is a potent, selective and ATP competitive inhibitor of JAK3.
For research use only. Not for human or veterinary use.
Research area
Inflammation/Immunology
Purity >98%
Stock Inquire
ZM 449829 structure
CAS No.: 4452-06-6
Pack sizes & pricing
Description
ZM 449829 is a potent, selective and ATP competitive inhibitor of JAK3, with a pIC50 of 6.8. ZM 449829 will be useful pharmacological tools for the investigation of the JAK3 .
Biological activity
In Vitro ZM 449829 (compound 22) is a very weak inhibitors of EGF-R (pIC50=5.0) , Jak1 (pIC50=4.7), and tyrosine kinases Lck and CDK4 (pIC50 <5.0). ZM449829 (1 μM; 30 minutes) blocks IL-2-induced STAT5 phosphorylation
Identifiers
- SMILES
-
C=CC(C1=CC=C2C=CC=CC2=C1)=O - InChIKey
-
FOTCGZPFSUWZBN-UHFFFAOYSA-N
Specifications
- MW (average)
- 182.2179
- Formula
- C13H10O
- CAS No.
- 4452-06-6
- Physical state
- Solid
- Color
- white to off-white
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder 4℃ 2 year; In solvent -20℃ 1 month;
Solubility
soluble in DMSO
- In vitro
- DMSO : 100 mg/mL
Documents
References
[1]. Brown GR, et, al. Naphthyl ketones: a new class of Janus kinase 3 inhibitors. Bioorg Med Chem Lett. 2000 Mar 2010(6)575-9.
[2]. Orange JS, et, al. IL-2 induces a WAVE2-dependent pathway for actin reorganization that enables WASp-independent human NK cell function. J Clin Invest. 2011 Apr; 121(4): 1535-48.
Same target
Search JAK- BP-00923 MTX-531 free base · >98%
- BP-01260 Rezivertinib free base · >98%
- BP-01841 CYT-387 free base · >98%
- BP-01851A Icotinib hydrochloride salt · >98%
- BP-01858A Derazantinib hydrochloride salt · >98%
- BP-01896 EGF816 free base · >98%
- BP-01903 Deucravacitinib free base · >99%
- BP-01908 AZD3759 free base · >99%